On February 16, 2023, Chen Qinming, Vice President of Lishui Institute for Food and Drug Control and Quality Inspection, and her entourage visited Zhejiang Benefit Pharmaceutical to carry out assistance activities. Wu Lihua, Chairman of the company, and heads of relevant departments warmly received them.

At the forum, Chairman Wu Lihua first extended a warm welcome to Vice President Chen Qinming and her entourage from Lishui Institute for Food and Drug Control and Quality Inspection, and expressed sincere gratitude to the Institute for the consistent support and help provided during the company's development.

President Chen and her team listened to the report on the company's operation and development, gained a detailed understanding of the enterprise's demands, and both sides conducted in-depth exchanges and discussions on aspects such as quality risk control of traditional Chinese medicine products, the whole-process quality management system for Chinese herbal pieces and formula granules, the construction of traceability system for Chinese herbal pieces, and the improvement of traditional Chinese medicine quality.

Subsequently, the leaders focused on visiting the company's laboratory, with key attention and guidance given to the physical and chemical room, sample retention room, and instrument room. While fully affirming the laboratory's testing area, experimental equipment, and facility conditions, President Chen stated that the company should formulate a sound quality monitoring system based on actual needs and problem orientation, ensuring that drug inspection personnel operate in accordance with standardized drug inspection procedures.

In the next step, Benefit will adhere to the strategic positioning of modern traditional Chinese medicine industry development, build its brand, optimize its team, persist in scientific research and innovation, further strengthen confidence, enhance factor support, and continue to do a good job in the production, research and development, and sales of Chinese herbal pieces and formula granules with higher standards. It will ensure product quality, expand, strengthen, optimize, and refine the advantages of characteristic products, continue to explore the depth of traditional Chinese medicine products, and achieve a new round of leap in innovative development.